Previous 10 | Next 10 |
2024-02-07 16:25:45 ET More on Rapid7 2024 Will Be A Good Year For Rapid7 Rapid7: Quality Business Trading Attractively In A Thriving Industry Rapid7 Q4 2023 Earnings Preview Rapid7 rises as UBS bumps rating higher on solid security services Seeking A...
Annualized recurring revenue (“ARR”) of $806 million, an increase of 13% year-over-year Full-year revenue of $778 million, up 14% year-over-year; Products revenue of $740 million, up 14% year-over-year Full-year GAAP operating loss of $81 million; Full-year non-GAAP operatin...
Penske Automotive Group Inc. (PAG) is expected to report $3.66 for Q4 2023 Copa Holdings S.A. Class A (CPA) is expected to report $3.9 for Q4 2023 Wynn Resorts Limited (WYNN) is expected to report $1.12 for Q4 2023 U-Haul Holding Co Com (UHAL) is expected to report $0.82 for Q3 2024 ...
BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced a new Managed Digital Risk Protection (DRP) service for external threat monitoring and remediation that prevents attacks earlier in the threat life...
2024-01-31 10:29:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In an era where digital connectivity is both a boon and a bane, the rising cyber threats have effectively turned the spotlight on cybersecurity stock picks 2024. While opening doors to new sect...
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous...
2024-01-30 11:02:09 ET More on CrowdStrike CrowdStrike: Even The Leader Of The Pack Needs To Rest Now And Again CrowdStrike: Valuation Looks Stretched 3 Reasons You Should Consider Selling Your Shares Of CrowdStrike Crowdstrike slips as WestPark Capital cuts ...
2024-01-29 09:38:35 ET More on Rapid7 2024 Will Be A Good Year For Rapid7 Rapid7: Quality Business Trading Attractively In A Thriving Industry Rapid7, Inc. 2023 Q3 - Results - Earnings Call Presentation Rapid7 rises amid Wolfe upgrade on strong Q3 Rap...
2024-01-14 05:18:01 ET Summary Rapid7's financial prospects for this year are positive, with strong revenue growth and margin improvement expected. The company's consensus revenue expansion estimate for 2024 is aligned with the market's expectations of an increase in cybersecurity...
2024-01-11 23:58:36 ET Summary RPD’s revenue has grown impressively well (CAGR +30%). Management has developed a compelling business model, with a broad range of services, underpinned by modern technologies. RPD is gaining market share and continues to innovate (supplemente...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...
2024-07-09 22:15:01 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for RPD on July 9, 2024 09:06PM ET. The previous analyst recommendation was Equal-Weight. RPD was trading at $39.72 at issue of the analyst recommendation. The overall analyst consensus : BU...